↓ Skip to main content

A cost effectiveness analysis of the preferred antidotes for acute paracetamol poisoning patients in Sri Lanka

Overview of attention for article published in BMC Clinical Pharmacology, February 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
4 X users

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A cost effectiveness analysis of the preferred antidotes for acute paracetamol poisoning patients in Sri Lanka
Published in
BMC Clinical Pharmacology, February 2012
DOI 10.1186/1472-6904-12-6
Pubmed ID
Authors

S M D K Ganga Senarathna, Shalini Sri Ranganathan, Nick Buckley, Rohini Fernandopulle

Abstract

Acute paracetamol poisoning is a rapidly increasing problem in Sri Lanka. The antidotes are expensive and yet no health economic evaluation has been done on the therapy for acute paracetamol poisoning in the developing world. The aim of this study is to determine the cost effectiveness of using N-acetylcysteine over methionine in the management of acute paracetamol poisoning in Sri Lanka.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 27%
Researcher 4 12%
Student > Ph. D. Student 3 9%
Other 3 9%
Student > Doctoral Student 2 6%
Other 8 24%
Unknown 4 12%
Readers by discipline Count As %
Medicine and Dentistry 13 39%
Pharmacology, Toxicology and Pharmaceutical Science 5 15%
Nursing and Health Professions 3 9%
Social Sciences 3 9%
Economics, Econometrics and Finance 2 6%
Other 3 9%
Unknown 4 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 December 2015.
All research outputs
#14,777,452
of 25,654,806 outputs
Outputs from BMC Clinical Pharmacology
#43
of 60 outputs
Outputs of similar age
#96,266
of 169,764 outputs
Outputs of similar age from BMC Clinical Pharmacology
#6
of 7 outputs
Altmetric has tracked 25,654,806 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 60 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.4. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 169,764 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one.